Pancreatic cancer trials in Norway

In Norway 19 Also abroad 1095

19 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Where
Oslo
Age
12 years and over
People
355 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00
Phase 2Taking people
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Where
Bergen, Oslo
Age
18 years and over
People
254 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07492680
Phase 3Taking people
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Where
Bergen, Oslo, Stavanger, Trondheim
Age
18 years and over
People
588 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07522073
Phase 2Taking people
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Where
Lørenskog, Oslo
Age
18 years and over
People
740 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00
Phase 3Not yet taking people in Norway
Phase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
Where
Oslo
Age
18 years and over
People
233 worldwide
Run by
Revolution Medicines Inc.
See details and how to join2025-524969-24-00 · EU 2025-524969-24-00
Phase 1/2Taking people
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
Where
Lørenskog, Oslo, Stavanger
Age
18 years and over
People
346 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06885034
Phase 3Taking people
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Where
Oslo, Trondheim
Age
18 years and over
People
900 worldwide
Run by
Revolution Medicines, Inc.
See details and how to joinNCT07491445 · EU 2025-525088-34-00
Phase 3Taking people
Phase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma
Where
Drammen
Age
18 years and over
People
281 worldwide
Run by
Revolution Medicines Inc.
See details and how to join2025-524928-21-00 · EU 2025-524928-21-00
Phase 3Taking people
A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
Where
Bergen, Oslo, Stavanger, Trondheim
Age
18 years and over
People
239 worldwide
Run by
Incyte Corp.
See details and how to join2025-525009-18-00 · EU 2025-525009-18-00
No phaseTaking people
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
Where
Bergen
Age
18 years to 99 years
People
24,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT05663515
Phase 4Taking people
Preventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortisone, ocreotide, and teres ligament patch (PANENCA): an international randomized controlled multicenter trial
Where
Oslo
Age
18 years and over
People
460 worldwide
Run by
Amsterdam UMC Stichting
See details and how to join2024-519667-18-00 · EU 2024-519667-18-00
No phaseNot yet taking people in Norway
Personalised Nutritional Care in Older Patients With Pancreatic Ductal Adenocarcinoma
Where
Bergen
Age
65 years and over
People
250 worldwide
Run by
Inna Chen, MD
See details and how to joinNCT07821554
Phase 2Taking people
A Phase II trial of ginisortamab in participants with metastatic pancreatic ductal adenocarcinoma
Where
Oslo
Age
18 years and over
People
43 worldwide
Run by
Cancer Research UK
See details and how to join2024-514129-43-00 · EU 2024-514129-43-00
Phase 3Taking people
Antiplatelet therapy added to standard thromboprophylaxis to prevent thrombosis in pancreatic cancer patients - a randomized clinical trial (The PANART trial)
Where
Bodo, Drammen, Graalum, Lorenskog, Trondheim
Age
18 years and over
People
744
Run by
Akershus University Hospital
See details and how to join2023-509022-22-00 · EU 2023-509022-22-00
No phaseTaking people
En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve the Overall Survival in Patients With Non-resectable Hilar Cholangiocarcinoma Beyond the Mayo Clinic Transplant Criteria
Where
Oslo
Age
18 years to 70 years
People
15
Run by
Oslo University Hospital
See details and how to joinNCT06850753
No phaseTaking people
A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer
Where
Bergen, Oslo, Stavanger, Tromsø, Trondheim
Age
18 years and over
People
400
Run by
Oslo University Hospital
See details and how to joinNCT06944587
Phase 4Taking people
Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery
Where
Oslo
Age
18 years to 120 years
People
800 worldwide
Run by
Helsinki University Central Hospital
See details and how to joinNCT05245877
No phaseTaking people
Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms
Where
Oslo
Age
18 years and over
People
20
Run by
Oslo University Hospital
See details and how to joinNCT05243082
No phaseEnrolling by invitation
The PREPAIRD Study: Personalized Surveillance for Early Detection of Pancreatic Cancer in High Risk Individuals
Where
Oslo
Age
30 years to 80 years
People
200
Run by
Oslo University Hospital
See details and how to joinNCT05740111